InvestorsHub Logo
icon url

crfrost

03/04/13 5:18 PM

#43548 RE: Carlsonjr25 #43547

Thinking you are onto something here, it's going to spring like a mouse trap.
Will be lots of shoulda coulda's ---------> watch " news trumps all "
icon url

bytor

03/04/13 5:24 PM

#43553 RE: Carlsonjr25 #43547

I couldn't agree more. We still have the late filing of the 10k looming which IMO has to be tied to a significant event. The application for Orphan drug status should also have a big impact . Lots of Good things in the hopper! BMSN
icon url

BennySlots

03/04/13 5:26 PM

#43554 RE: Carlsonjr25 #43547

That's what's so great about BMSN! A lot of these penny stocks are just plain bad business ideas and only get play from pump and dump promos. But BMSN seems like a fledgling Biotech company that's starting to get it's gears turning and is about to start going places. I think 2013 is gonna be the year that stem cell therapies really start breaking out. And we're on the ground floor of that here with BMSN.

So yeah, it's not just the IND approval. Moving forward, I see the following:

1. Filing for Orphan Drug Status
2. Orphan Drug Status approval
3. Begin human trials
4. Updates during human trials
5. Act on their LOI to acquire the gene silencing treatment for breast cancer
6. Whatever the next steps are for that therapy after the patent acquisition.
7. And more?

So yeah, BMSN seems like a rare legitimate really long play in penny land. Getting the IND approval will instill confidence that they can follow through with these future steps. Which will also probably open them up for other sources of funding as well.

Exciting times. GO BMSN!
icon url

steve837

03/04/13 9:32 PM

#43597 RE: Carlsonjr25 #43547

The simple answer is that most are in this stock for the potential pps pop that an IND go ahead from the FDA would provide.

You can include me in that group. If there was no HemaXellerate IND, then an LOI would not induce me to invest in BMSN.

I am not here because of a letter of future intent: I am here first and foremost to make money -- an FDA approval for clinical trials and then possible orphan drug status is the enchilada. That will make me money.